| Introduction: This study was conducted to evaluate OX26-PEG-coated gold nanoparticles
(GNPs) (OX26@GNPs) as a novel targeted nanoparticulate system on cell survival after
ischemic stroke.
Materials and methods: Dynamic light scattering (DLS), zeta sizer, and transmission
electron microscopy (TEM) were performed to characterize the OX26@GNPs. The effect of
OX26@GNPs on infarct volume, neuronal loss, and necroptosis was evaluated 24 h after
reperfusion using 2, 3,5-Triphenyltetrazolium chloride (TTC) staining, Nissl staining and
Western blot assay, respectively.
Results: Conjugation of OX26-PEG to the surface of the 25 nm colloidal gold particles
increased their size to 32±2 nm, while a zeta potential change of −40.4 to 3.40 mV
remarkably increased the stability of the nanoparticles. Most importantly, OX26@GNPs
significantly increased the infarcted brain tissue, while bare GNPs and PEGylated GNPs
had no effect on the infarct volume. However, our results indicated an extension of necroptotic
cell death, followed by cell membrane damage.
Conclusion: Collectively, our results showed that the presently formulated OX26@GNPs
are not suitable nanocarriers nor contrast agents under oxidative stress for the diagnosis and
treatment of ischemic stroke. Moreover, our findings suggest that the cytotoxicity of GNPs in
the brain is significantly associated with their surface charge.
Keywords: targeted delivery, gold nanoparticles, necroptosis, surface charge, oxidative
stress, cytotoxicity |